BlackRock Fund Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

BlackRock Fund Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$71.8M	Buy	3,900,323 +815,286	+26%	+$15.9M	0.01%	1436
2016 Q3	$58.5M	Buy	3,085,037 +1,581,978	+105%	+$28.7M	0.01%	1466
2016 Q2	$24.2M	Buy	1,503,059 +100,111	+7%	+$1.41M	0.01%	1923
2016 Q1	$16.8M	Buy	1,402,948 +31,391	+2%	+$370K	﹤0.01%	2081
2015 Q4	$19.5M	Sell	1,371,557 -106,475	-7%	-$1.41M	﹤0.01%	2058
2015 Q3	$17.3M	Buy	1,478,032 +77,541	+6%	+$1.16M	﹤0.01%	2084
2015 Q2	$24.6M	Buy	1,400,491 +580,117	+71%	+$9.04M	0.01%	1987
2015 Q1	$12.3M	Buy	820,374 +43,930	+6%	+$587K	﹤0.01%	2336
2014 Q4	$9.02M	Buy	776,444 +549,026	+241%	+$5.98M	﹤0.01%	2523
2014 Q3	$2.65M	Buy	+227,418	New	+$2.37M	﹤0.01%	3068

Other funds holding AMPH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock Fund Advisors's AMPH Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Amphastar Pharmaceuticals (AMPH) stake by 26% in Q4 2016, buying an estimated $15.9M and bringing the position to 3,900,323 shares worth $71.8M. The position accounts for 0.01% of the portfolio, ranked #1436.

BlackRock Fund Advisors first reported a position in AMPH in Q3 2014 and has held it in 10 quarters since. 138 funds tracked by Wall St. Rank hold AMPH as of Q4 2016.

BlackRock Fund Advisors held 3,900,323 shares of Amphastar Pharmaceuticals worth $71.8M as of Q4 2016.
BlackRock Fund Advisors bought 815,286 Amphastar Pharmaceuticals shares in Q4 2016, an estimated $15.9M.
Amphastar Pharmaceuticals made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1436 holding.
BlackRock Fund Advisors first reported a position in Amphastar Pharmaceuticals in Q3 2014 and has held it in 10 quarters since.
138 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.